A selective androgen receptor modulator, S4, displays robust anti-cancer activity on hepatocellular cancer cells by negatively regulating PI3K/AKT/mTOR signalling pathway - ScienceDirect
5
$ 7.99
In stock
(798)
Product Description
Metabolic network-based stratification of hepatocellular carcinoma
Expanding therapeutic targets in bladder cancer: the PI3K/Akt/mTOR
IJMS, Free Full-Text
The microenvironmental and metabolic aspects of sorafenib
p53 haploinsufficiency and increased mTOR signalling define a
Novel Platinum Nanoclusters Activate PI3K/AKT/mTOR Signaling
Overview of the PI3K/AKT/mTOR signaling pathway in prostate cancer
IJMS, Free Full-Text
The emerging role of the PI3-K-Akt pathway in prostate cancer
Novel Platinum Nanoclusters Activate PI3K/AKT/mTOR Signaling
A selective androgen receptor modulator, S4, displays robust anti
Status of PI3K inhibition and biomarker development in cancer
IJMS, Free Full-Text
